Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers
暂无分享,去创建一个
Mark Pinches | R. Arani | Ramin Arani | David A Brott | Scott H Adler | Susan C Lovick | Stephen T Furlong | S. Furlong | S. Adler | D. Brott | M. Pinches | S. Lovick
[1] F. Grenier,et al. Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. , 2010, Clinical biochemistry.
[2] B. Ripley,et al. Robust Statistics , 2018, Wiley Series in Probability and Statistics.
[3] T. Daly,et al. Analytical and biological validation of a multiplex immunoassay for acute kidney injury biomarkers. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[4] J. Norenberg,et al. Assessment of Effective Renal Plasma Flow, Enzymuria, and Cytokine Release in Healthy Volunteers Receiving a Single Dose of Amphotericin B Desoxycholate , 2005, Antimicrobial Agents and Chemotherapy.
[5] P. S. Horn,et al. A robust approach to reference interval estimation and evaluation. , 1998, Clinical chemistry.
[6] Krishna Prasad,et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium , 2010, Nature Biotechnology.
[7] J. Pickering,et al. Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. , 2012, Journal of the American Society of Nephrology : JASN.
[8] J. F. Wallace,et al. CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL. , 1965, The New England journal of medicine.
[9] Z. Endre,et al. Renal biomarkers predict nephrotoxicity after paraquat. , 2013, Toxicology letters.
[10] J. Bakker,et al. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges , 2012, Clinical kidney journal.
[11] D. Pollock,et al. National surveillance of emergency department visits for outpatient adverse drug events. , 2006, JAMA.
[12] M. Gehrmann,et al. Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] Syril Pettit,et al. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[14] Sushrut S Waikar,et al. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. , 2010, Kidney international.
[15] M. Rosner,et al. Acute kidney injury. , 2009, Current drug targets.
[16] Rebecca A Betensky,et al. Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans , 2008, Clinical and translational science.
[17] R. Strohal,et al. Early detection of renal damage caused by fumaric acid ester therapy by determination of urinary β2‐microglobulin , 2011, The British journal of dermatology.
[18] S. Goldstein. Urinary kidney injury biomarkers and urine creatinine normalization: a false premise or not? , 2010, Kidney international.
[19] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[20] R. Cully,et al. Weekly clinicopathological exercises. , 1990, The New England journal of medicine.
[21] N. Ambalavanan,et al. Urine biomarkers predict acute kidney injury in newborns. , 2012, The Journal of pediatrics.
[22] D. Pollock,et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. , 2008, The Journal of pediatrics.
[23] S. Waikar,et al. Urinary biomarkers in the early diagnosis of acute kidney injury. , 2008, Kidney international.
[24] H E Solberg,et al. Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values. , 1988, Clinica chimica acta; international journal of clinical chemistry.
[25] Kiyoshi Ichihara,et al. An appraisal of statistical procedures used in derivation of reference intervals , 2010, Clinical chemistry and laboratory medicine.
[26] M. Aydoğdu,et al. The Use of Plasma and Urine Neutrophil Gelatinase Associated Lipocalin (NGAL) and Cystatin C in Early Diagnosis of Septic Acute Kidney Injury in Critically Ill Patients , 2013, Disease markers.
[27] Serafino Pantano,et al. Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury , 2010, Nature Biotechnology.
[28] R. Wind,et al. Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers , 2010, British Journal of Nutrition.
[29] M. W. Ogden,et al. Effect of creatinine and specific gravity normalization techniques on xenobiotic biomarkers in smokers' spot and 24-h urines. , 2006, Journal of pharmaceutical and biomedical analysis.
[30] J P Kriss,et al. Limitations of creatinine as a filtration marker in glomerulopathic patients. , 1985, Kidney international.
[31] Daisuke Sasaki,et al. Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[32] D. Guinee,et al. Clinically silent progressive renal tubulointerstitial disease during cisplatin chemotherapy , 1993, Cancer.
[33] S. Pettit,et al. Biomarkers of Collecting Duct Injury in Han-Wistar and Sprague-Dawley Rats Treated with N-Phenylanthranilic Acid , 2012, Toxicologic pathology.
[34] A. Köttgen,et al. Trefoil Factor 3 Predicts Incident Chronic Kidney Disease: A Case-Control Study Nested within the Atherosclerosis Risk in Communities (ARIC) Study , 2011, American Journal of Nephrology.
[35] A. Kratz,et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. , 2004, The New England journal of medicine.
[36] H E Solberg,et al. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values. Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference , 1988, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[37] E. Rozet,et al. Urinary NGAL measurement: biological variation and ratio to creatinine. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[38] Annabelle Heier,et al. Assessment of biomarkers of drug-induced kidney injury in cynomolgus monkeys treated with a triple reuptake inhibitor. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[39] Amy G. Aslamkhan,et al. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury , 2010, Nature Biotechnology.
[40] T. Skopek,et al. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function , 2010, Nature Biotechnology.
[41] W. van Biesen,et al. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[42] C. Faes,et al. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue? , 2013, Clinical chemistry and laboratory medicine.
[43] E. Honkanen. [Treatment of acute renal failure]. , 1998, Duodecim; laaketieteellinen aikakauskirja.
[44] N. Ambalavanan,et al. Urine biomarkers predict acute kidney injury and mortality in very low birth weight infants. , 2011, The Journal of pediatrics.
[45] M. Takashi,et al. Urinary 28-kD calbindin-D as a new marker for damage to distal renal tubules caused by cisplatin-based chemotherapy. , 1996, Urologia internationalis.
[46] Ling Han,et al. Comparison of Urinary Biomarkers for Early Detection of Acute Kidney Injury After Cardiopulmonary Bypass Surgery in Infants and Young Children , 2013, Pediatric Cardiology.
[47] C. Krawczeski,et al. Proteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[48] Hannes Planatscher,et al. A generic operational strategy to qualify translational safety biomarkers. , 2011, Drug discovery today.
[49] C. Betts,et al. Evaluation of Novel Renal Biomarkers with a Cisplatin Model of Kidney Injury: Gender and Dosage Differences , 2012, Toxicologic pathology.
[50] J. Yee,et al. Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. , 2003, Kidney international.
[51] M. Earing,et al. Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine. , 2012, Congenital heart disease.
[52] Michael L. Bentley,et al. Drug-induced acute kidney injury in the critically ill adult: Recognition and prevention strategies , 2010, Critical care medicine.